4Wolf-Walther du Mont,Govindasamy Mugesh,Cathleen Wismach,et al. Reactions of Organoselenenyl Iodides with Thiouracil Drugs: An Enzyme Mimetic Study on the Inhibition of Iodothyronine Deiodinase[J],Angew Chem Int Ed 2001, 40(13):2486-2489.
5Persson Moschos ME,Stavenow L, Akesson B, et al. Selenoprotein P in plasma in relation to cancer mobidity in middle-aged Swedish men[J]. Nutr Cancer,2000,36(1):19-26.
6Rayman MP. The importance of selenium to human health[J]. The Lancet,2000,356:233-241.
7Medical Economics Company. PDR (Physician′s Desk Reference) for Nutritional Supplements [M]. Montvale, New Jersey. 2001.417
8Whanger PD. Selenoprotein W: a review[J]. Cellular and Molecular Life Sciences,2000,57:1846-1852.
9Moschos MP. Selenoprotein P[J]. Cellular and Molecular Life Sciences,2000,57:1836-1845.
5[1]Gladyshev VN,Jeang K,Wootton JC,et al. A new human selenium containingg protein. J. Biol. Chem, 1998,273:8910～8915
6[2]Ip C,Thompson HJ,Zhu Z,et al. In vitro and in vivo studies of methylseleninic acid: evidence that a monomathylated selenium mataboliteis critical for cancer chem oprevention. Cancer Res , 2000,60: 2882 ～ 6
7[3]Andreadou I,Water B,Commander JNM,et al. Comparative cytotoxicity of 14 novel selenocysteine Se- conjugates in rat renal proximal tubular cells. Toxicol. Apk.Pharmacok, 1996,141: 278～287
8[4]Kaeca ML,Lu J,Strange R,et al. Differential indruction of growth arrest inducible genes by selenium compounds. Biochem. Pharmacol, 1997,53: 921-926
9[5]Sinha R,Medina D. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammaryepithelial tumor cells. Carcinogenesis, 1997, 18:1541 ～1547
10[6]Howard EG. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis, 1999,20: 1657 ～1666
